ATS 2024 Archives - Medical Conferences

Home > Pulmonology > ATS 2024

Read the full Report (pdf)

American Thoracic Society 17-22 May 2024 San Diego, CA, USA

ZEPHYRUS-1: Pamrevlumab fails in IPF

Presented By

Dr Ganesh Raghu, UW Medical Center, WA, USA

Trial

Phase 3, ZEPHYRUS-1

Conference

ATS 2024

Type

News article

11 June 2024 10:29

NOTUS: Dupilumab safe and efficacious in COPD with type 2 inflammation

Presented By

Dr Surya Bhatt, University of Alabama at Birmingham, AL, USA

Trial

Phase 3, NOTUS

Conference

ATS 2024

Type

News article

10 June 2024 17:37

Sulthiame may be the next treatment for OSA

Presented By

Dr Jan Hedner, University of Gothenburg, Sweden

Trial

Phase 2, STM-042/K

Conference

ATS 2024

Type

News article

10 June 2024 16:34

Online First

Miscellaneous Topics

Pirfenidone may alleviate disease burden in DRCB

Presented By

Ms Helen Hicks, University of Michigan, MI, USA

Conference

ATS 2024

Type

News article

11 June 2024 11:11

Can mindfulness reduce depression and anxiety in ICU survivors?

Presented By

Dr Catherine Hough, Oregon Health & Science University, OR, USA

Trial

Phase 3, LIFT-2

Conference

ATS 2024

Type

News article

11 June 2024 11:06

Exercise and diet improve functional status in PAH

Presented By

Dr Gustavo Heresi, Cleveland Clinic, OH, USA

Trial

PHINE

Conference

ATS 2024

Type

News article

11 June 2024 10:58

Idiopathic Pulmonary Fibrosis

STARSCAPE: Zinpentraxin alfa does not ameliorate health status in IPF

Presented By

Prof. Luca Richeldi, University of Southampton, UK

Trial

Phase 3, STARSCAPE

Conference

ATS 2024

Type

News article

11 June 2024 10:51

ZEPHYRUS-1: Pamrevlumab fails in IPF

Presented By

Dr Ganesh Raghu, UW Medical Center, WA, USA

Trial

Phase 3, ZEPHYRUS-1

Conference

ATS 2024

Type

News article

11 June 2024 10:29

COPD

Can we safely use betablockers in COPD?

Presented By

Dr Bryan Lipworth, University of Dundee, UK

Trial

BLOCK

Conference

ATS 2024

Type

News article

11 June 2024 10:26

COURSE: Encouraging results for tezepelumab in COPD

Presented By

Prof. Dave Singh, University of Manchester, UK

Trial

Phase 2, COURSE

Conference

ATS 2024

Type

News article

11 June 2024 10:18

Ensifentrine delays transition from GOLD B to GOLD E in COPD

Presented By

Dr Frank Sciurba, University of Pittsburgh, PA, USA

Trial

ENHANCE

Conference

ATS 2024

Type

News article

11 June 2024 10:12

NOTUS: Dupilumab safe and efficacious in COPD with type 2 inflammation

Presented By

Dr Surya Bhatt, University of Alabama at Birmingham, AL, USA

Trial

Phase 3, NOTUS

Conference

ATS 2024

Type

News article

10 June 2024 17:37

BOREAS: Blood eosinophil count and FeNO levels predictive of dupilumab response in COPD

Presented By

Dr Stephanie Christenson , University of California San Francisco, CA, USA

Trial

Phase 3, BOREAS

Conference

ATS 2024

Type

News article

10 June 2024 17:30

Respiratory Infections

Two regimens deliver high sputum conversion rates in M. xenopi pulmonary infection

Presented By

Prof. Claire Andrejak, CHU Amiens, France

Trial

Phase 3, CaMoMy

Conference

ATS 2024

Type

News article

10 June 2024 17:26

Patient-reported outcomes improve practice in MAC lung disease

Presented By

Dr Charles Daley, University of Colorado, CO, USA

Trial

Phase 3, ARISE

Conference

ATS 2024

Type

News article

10 June 2024 17:18

Novel RSV vaccine to prevent serious respiratory illness

Presented By

Dr Daniel Eiras, Pfizer, NY, USA

Trial

Phase 3, RENOIR

Conference

ATS 2024

Type

News article

10 June 2024 17:11

Asthma

UCAP: Identify and treat undiagnosed COPD or asthma

Presented By

Dr Shawn Aaron, Ottawa Hospital Research Institute, Canada

Conference

ATS 2024

Type

News article

10 June 2024 17:04

Structural and functional lung improvement with dupilumab in asthma

Presented By

Dr George Washko, Brigham and Women’s Hospital, MA, USA

Trial

Phase 4, VESTIGE

Conference

ATS 2024

Type

News article

10 June 2024 16:57

Obstructive Sleep Apnea

Is the Apnea Hypopnea Index ready to be replaced?

Presented By

Dr Sajila Wickramaratne, Icahn School of Medicine at Mount Sinai, NY, USA

Conference

ATS 2024

Type

News article

10 June 2024 16:47

Does PAP therapy truly reduce mortality in OSA?

Presented By

Dr Atul Malhotr, University of California San Diego, CA, USA

Conference

ATS 2024

Type

News article

10 June 2024 16:41

Sulthiame may be the next treatment for OSA

Presented By

Dr Jan Hedner, University of Gothenburg, Sweden

Trial

Phase 2, STM-042/K

Conference

ATS 2024

Type

News article

10 June 2024 16:34

Medical Conferences

ATS 2024

Featured articles

ZEPHYRUS-1: Pamrevlumab fails in IPF

NOTUS: Dupilumab safe and efficacious in COPD with type 2 inflammation

Sulthiame may be the next treatment for OSA

CONTENTS

Online First

Miscellaneous Topics

Pirfenidone may alleviate disease burden in DRCB

Can mindfulness reduce depression and anxiety in ICU survivors?

Exercise and diet improve functional status in PAH

Idiopathic Pulmonary Fibrosis

STARSCAPE: Zinpentraxin alfa does not ameliorate health status in IPF

ZEPHYRUS-1: Pamrevlumab fails in IPF

COPD

Can we safely use betablockers in COPD?

COURSE: Encouraging results for tezepelumab in COPD

Ensifentrine delays transition from GOLD B to GOLD E in COPD

NOTUS: Dupilumab safe and efficacious in COPD with type 2 inflammation

BOREAS: Blood eosinophil count and FeNO levels predictive of dupilumab response in COPD

Respiratory Infections

Two regimens deliver high sputum conversion rates in M. xenopi pulmonary infection

Patient-reported outcomes improve practice in MAC lung disease

Novel RSV vaccine to prevent serious respiratory illness

Asthma

UCAP: Identify and treat undiagnosed COPD or asthma

Structural and functional lung improvement with dupilumab in asthma

Obstructive Sleep Apnea

Is the Apnea Hypopnea Index ready to be replaced?

Does PAP therapy truly reduce mortality in OSA?

Sulthiame may be the next treatment for OSA